Literature DB >> 18496422

Immunohistochemical distinction of cutaneous spindle cell carcinoma.

Michael B Morgan1, Chetna Purohit, Tiffany R Anglin.   

Abstract

Cutaneous spindle cell squamous carcinoma is an uncommon variant of squamous cell carcinoma in which keratinocytes infiltrate the dermis as single cells with elongated nuclei rather than as cohesive nests or islands, and signs of keratinization of conventional squamous cell carcinoma are insubstantial or nonexistent. Spindle cell carcinoma must be distinguished from spindle cell/desmoplastic melanoma, cutaneous leiomyosarcoma, atypical fibroxanthoma (AFX), and scar. In instances when there is no definitive evidence of squamous differentiation, immunohistochemical studies may confer diagnostic discrimination. Twenty-four cases consisting of 12 spindle cell squamous cell carcinomas, 3 AFXs, 3 leiomyosarcomas, 3 desmoplastic melanomas, and 3 scars were evaluated with a battery of immunohistochemical stains, with the specificity and sensitivity of each marker calculated. The immunohistochemical battery consisted of S-100, desmin, CD68, and smooth muscle actin and cytokeratins P KER (keratins predominantly of molecular weight 56 and 69 kd) and low-molecular weight keratin (CAM 5.2), AE1/AE3, p63, and 34 beta E12 (CK903). Spindle cell squamous carcinomas were negative for S-100, CD68, smooth muscle actin, and desmin with the exception of 2 cases with weak staining for smooth muscle actin. 34 beta E12 provided positive results for each spindle cell squamous carcinoma. The other cytokeratin stains were less sensitive for spindle cell squamous carcinoma than 34 beta E12. The final immunohistochemical results were as follows: 34 beta E12 (12/12, 100%), p63 (10/12, 80%), AE1/AE3 (8/12, 67%), low-molecular weight keratin (7/12, 58%), and P KER (4/12, 33%). The 3 AFXs were positive for CD68 and negative for all other stains, whereas the 3 leiomyosarcomas stained positively for desmin and smooth muscle actin and negatively for all other stains. The 3 melanomas stained positively for S-100 and negatively for all other immunohistochemistry. The scars were negative for all stains. In conclusion, our study of 34 beta E12 proved most promising in distinguishing spindle cell squamous carcinoma from the histologic mimickers, AFX, spindle cell melanoma, scar, and leiomyosarcoma.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18496422     DOI: 10.1097/DAD.0b013e31816de820

Source DB:  PubMed          Journal:  Am J Dermatopathol        ISSN: 0193-1091            Impact factor:   1.533


  15 in total

1.  Occasional staining for p63 in malignant vascular tumors: a potential diagnostic pitfall.

Authors:  Michael E Kallen; Flavia G Nunes Rosado; Adriana L Gonzalez; Melinda E Sanders; Justin M M Cates
Journal:  Pathol Oncol Res       Date:  2011-06-13       Impact factor: 3.201

2.  Primary hepatic sarcomatoid carcinoma: A case report.

Authors:  Qianying Leng; X I Xiang; Yuanjiao Tang; Yujia Yang; L I Qiu
Journal:  Exp Ther Med       Date:  2015-06-29       Impact factor: 2.447

3.  A Case of Cutaneous Spindle Cell Squamous Cell Carcinoma Arising in a Nevus Sebaceous.

Authors:  Yong Woo Oh; Dong Hee Kim; Byeong Hak Seo; Ho Seok Suh; Yu Sung Choi
Journal:  Ann Dermatol       Date:  2020-03-11       Impact factor: 1.444

Review 4.  Diagnostic and prognostic biomarkers in melanoma.

Authors:  David Weinstein; Jennifer Leininger; Carl Hamby; Bijan Safai
Journal:  J Clin Aesthet Dermatol       Date:  2014-06

5.  Cutaneous spindle cell squamous cell carcinoma.

Authors:  Joo Hee Lee; Young Bok Lee; Jin Wou Kim; Dong Soo Yu
Journal:  Ann Dermatol       Date:  2015-02-03       Impact factor: 1.444

6.  Cutaneous spindle cell carcinoma misdiagnosed as atypical fibroxanthoma based on immunohistochemical stains.

Authors:  Anastasia Benoit; Joshua Wisell; Mariah Brown
Journal:  JAAD Case Rep       Date:  2015-11-02

7.  p63 is an alternative p53 repressor in melanoma that confers chemoresistance and a poor prognosis.

Authors:  Rubeta N Matin; Anissa Chikh; Stephanie Law Pak Chong; David Mesher; Manuela Graf; Paolo Sanza'; Valentina Senatore; Maria Scatolini; Francesca Moretti; Irene M Leigh; Charlotte M Proby; Antonio Costanzo; Giovanna Chiorino; Rino Cerio; Catherine A Harwood; Daniele Bergamaschi
Journal:  J Exp Med       Date:  2013-02-18       Impact factor: 14.307

Review 8.  An Algorithmic Immunohistochemical Approach to Define Tumor Type and Assign Site of Origin.

Authors:  Andrew M Bellizzi
Journal:  Adv Anat Pathol       Date:  2020-05       Impact factor: 4.571

9.  Simulators of squamous cell carcinoma of the skin: diagnostic challenges on small biopsies and clinicopathological correlation.

Authors:  Kong-Bing Tan; Sze-Hwa Tan; Derrick Chen-Wee Aw; Huma Jaffar; Thiam-Chye Lim; Shu-Jin Lee; Yoke-Sun Lee
Journal:  J Skin Cancer       Date:  2013-06-25

Review 10.  Diagnostic Immunohistochemistry in Cutaneous Neoplasia: An Update.

Authors:  Leigh A Compton; George F Murphy; Christine G Lian
Journal:  Dermatopathology (Basel)       Date:  2015-04-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.